Novartis Europharm Limited

Active Company no. 03068306 Incorporated Jun 1995 W postcode area

2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London, W12 7FQ

The most recent insolvency notice for Novartis Europharm Limited is a Notices to creditors (MVL), published 08 October 2026 in The London Gazette. The office holders are Derek Neil Hyslop; Matthew Coomber, appointed 30 September 2026. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Last filed balance sheet

Not yet retrieved. Accounts are currently overdue at Companies House.

Insolvency notices (3)

Notices to creditors (MVL) 08 Oct 2026

The joint liquidators announce a final distribution to creditors of several companies, with a deadline of 20 November 2026 to submit claims.
Appointment of liquidators (MVL) 08 Oct 2026

Members appointed liquidators for several companies on 30 September 2026.
Resolution for winding up (MVL) 08 Oct 2026

The shareholders of six companies passed resolutions on 30 September 2026 to voluntarily wind them up and appointed Ernst & Young LLP partners as joint liquidators.

Owed money by Novartis Europharm Limited?

A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.

What to do when a customer fails

Related guidance

Frequently asked questions

Is Novartis Europharm Limited in financial difficulty?

No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Novartis Europharm Limited (company no. 03068306) is a Notices to creditors (MVL), published 08 October 2026 in The London Gazette.

What were Novartis Europharm Limited's last filed accounts?

Not yet retrieved for Novartis Europharm Limited at Companies House.

How many insolvency notices does Novartis Europharm Limited have?

Novartis Europharm Limited has 3 insolvency notices recorded in The London Gazette, the most recent being a Notices to creditors (MVL) on 08 October 2026.

About this page

Published by K2 Business Partners. Our founder has worked on the turnaround of struggling UK businesses since 1990, and K2 Partners Ltd has invested alongside company directors since 2001. The notice itself is reproduced from The London Gazette and matched to Companies House; the plain-English explanations are K2's. K2's partners include Tony Groom CTP — Certified Turnaround Professional, past President of the Turnaround Management Association UK and Turnaround Practitioner of the Year 2009 — and Mark Blayney MBA ACA, a chartered accountant specialising in the financial restructuring of SME businesses.

K2 does not act as insolvency practitioner on these cases. To make a claim, contact the office holder named in the relevant notice.

Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.